Jan Martin Berke

1.5k total citations
31 papers, 1.0k citations indexed

About

Jan Martin Berke is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jan Martin Berke has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 20 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Jan Martin Berke's work include Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (18 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jan Martin Berke is often cited by papers focused on Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (18 papers) and Liver Disease Diagnosis and Treatment (6 papers). Jan Martin Berke collaborates with scholars based in Belgium, United States and Switzerland. Jan Martin Berke's co-authors include Pascale Dehertogh, Karen Vergauwen, Koen Vandyck, Frederik Pauwels, Darius Moradpour, Oliver Lenz, Pierre Raboisson, Wendy Mostmans, Leen Vijgen and Maxwell D. Cummings and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Hepatology.

In The Last Decade

Jan Martin Berke

30 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Martin Berke Belgium 16 764 712 340 183 80 31 1.0k
Thierry Verbinnen Belgium 15 919 1.2× 841 1.2× 381 1.1× 84 0.5× 27 0.3× 39 1.0k
Christophe Hourioux France 19 727 1.0× 815 1.1× 194 0.6× 217 1.2× 79 1.0× 32 1.1k
Rakesh Tripathi United States 20 1.0k 1.3× 859 1.2× 579 1.7× 270 1.5× 14 0.2× 43 1.5k
Hyunsoon Kang United States 9 649 0.8× 495 0.7× 451 1.3× 173 0.9× 14 0.2× 11 795
Linda Bartholomew Italy 11 668 0.9× 505 0.7× 364 1.1× 237 1.3× 12 0.1× 14 962
Kenneth Simmen Belgium 20 753 1.0× 892 1.3× 459 1.4× 450 2.5× 23 0.3× 39 1.6k
Matthew F. McCown United States 8 290 0.4× 493 0.7× 259 0.8× 226 1.2× 26 0.3× 10 730
Julie Q. Hang United States 16 238 0.3× 228 0.3× 340 1.0× 257 1.4× 69 0.9× 20 718
Tony Whitaker United States 17 436 0.6× 410 0.6× 555 1.6× 324 1.8× 15 0.2× 36 1.0k
John Wickersham United States 8 340 0.4× 216 0.3× 126 0.4× 314 1.7× 73 0.9× 10 724

Countries citing papers authored by Jan Martin Berke

Since Specialization
Citations

This map shows the geographic impact of Jan Martin Berke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Martin Berke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Martin Berke more than expected).

Fields of papers citing papers by Jan Martin Berke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Martin Berke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Martin Berke. The network helps show where Jan Martin Berke may publish in the future.

Co-authorship network of co-authors of Jan Martin Berke

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Martin Berke. A scholar is included among the top collaborators of Jan Martin Berke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Martin Berke. Jan Martin Berke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berke, Jan Martin, Daitze Wu, Ke Zhang, et al.. (2024). Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation. Journal of Virology. 98(3). e0150223–e0150223. 4 indexed citations
2.
Lecoq, Lauriane, Marie‐Laure Fogeron, Shishan Wang, et al.. (2023). Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR. Nature Communications. 14(1). 471–471. 11 indexed citations
3.
Vergauwen, Karen, Steffen Jaensch, Emmanuel Gustin, et al.. (2021). Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures. Journal of Virological Methods. 293. 114150–114150. 6 indexed citations
4.
Verbinnen, Thierry, Willem Talloen, Jan Martin Berke, et al.. (2020). Virology analysis of chronic hepatitis B virus–infected patients treated for 28 days with JNJ‐56136379 monotherapy. Journal of Viral Hepatitis. 27(11). 1127–1137. 14 indexed citations
5.
Wang, Shishan, Marie‐Laure Fogeron, Susanne Penzel, et al.. (2019). Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. Frontiers in Molecular Biosciences. 6. 67–67. 20 indexed citations
6.
Vandenbossche, Joris, Wolfgang Jessner, Jeike Biewenga, et al.. (2019). Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects. Advances in Therapy. 36(9). 2450–2462. 23 indexed citations
7.
Geluykens, Peggy, Olivia Goethals, Stefaan Last, et al.. (2017). Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library. Antiviral Research. 147. 149–158. 15 indexed citations
8.
Berke, Jan Martin, Thierry Verbinnen, Pascale Dehertogh, et al.. (2017). Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro. Antiviral Research. 144. 205–215. 25 indexed citations
9.
10.
Vijgen, Leen, Jannick Verbeeck, Jan Martin Berke, et al.. (2013). A Cellular Replicon-Based Phenotyping Assay to Determine Susceptibility of Hepatitis C Virus Clinical Isolates to NS3/4A Protease Inhibitors. Methods in molecular biology. 1030. 105–117. 5 indexed citations
11.
Lenz, Oliver, Leen Vijgen, Jan Martin Berke, et al.. (2012). Virologic response and characterisation of HCV genotype 2–6 in patients receiving TMC435 monotherapy (study TMC435-C202). Journal of Hepatology. 58(3). 445–451. 69 indexed citations
12.
Jochmans, Dirk, R. Clayton, Jan Martin Berke, et al.. (2011). MAPPIT as a High-Throughput Screening Assay for Modulators of Protein–Protein Interactions in HIV and HCV. Methods in molecular biology. 812. 295–307. 6 indexed citations
13.
Berke, Jan Martin, Leen Vijgen, Sophie Lachau‐Durand, et al.. (2011). Antiviral Activity and Mode of Action of TMC647078, a Novel Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. Antimicrobial Agents and Chemotherapy. 55(8). 3812–3820. 6 indexed citations
14.
Berke, Jan Martin, Denis Fenistein, Frederik Pauwels, et al.. (2010). Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex. Journal of Virological Methods. 165(2). 268–276. 8 indexed citations
15.
Brass, Volker, Jan Martin Berke, Roland Montserret, et al.. (2008). Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex. Proceedings of the National Academy of Sciences. 105(38). 14545–14550. 100 indexed citations
16.
Berke, Jan Martin & Darius Moradpour. (2005). Hepatitis C virus comes full circle. Hepatology. 42(6). 1264–1269. 5 indexed citations
17.
Gosert, Rainer, et al.. (2005). Characterization of Nonstructural Protein Membrane Anchor Deletion Mutants Expressed in the Context of the Hepatitis C Virus Polyprotein. Journal of Virology. 79(12). 7911–7917. 9 indexed citations
18.
Duong, François H.T., et al.. (2005). Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1. Journal of Virology. 79(24). 15342–15350. 77 indexed citations
19.
20.
Pelner, Louis, et al.. (1951). Choline excretion in patients with and without diseases of the liver and in carcinoma of the gastro-intestinal tract.. PubMed. 9(1). 177–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thierry Verbinnen Breakdown of academic impact, for papers by Christophe Hourioux Breakdown of academic impact, for papers by Rakesh Tripathi Breakdown of academic impact, for papers by Hyunsoon Kang Breakdown of academic impact, for papers by Linda Bartholomew Breakdown of academic impact, for papers by Kenneth Simmen Breakdown of academic impact, for papers by Matthew F. McCown Breakdown of academic impact, for papers by Julie Q. Hang Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by John Wickersham
Rankless by CCL
2026